Journal of cardiology
-
Journal of cardiology · Jul 2020
Multicenter Study Observational StudyRegistry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study.
The incidence of cardiovascular diseases, including valvular heart disease and atrial fibrillation (AF), is rising as the elderly population increases. For patients with AF and bioprosthetic valves, current treatment guidelines for antithrombotic therapy vary by country, likely due to a lack of robust study data. ⋯ In a current real-world setting in Japan, warfarin was the most commonly used treatment in AF patients with bioprosthetic valves, but there was an increasing trend of DOAC-treated patients. Further investigations are needed to confirm the efficacy and safety of DOAC in patients with bioprosthetic valves.